Abstract
BACKGROUND AND PURPOSE: Calcified cerebral emboli are a rarely reported but devastating cause of stroke and may be the first manifestation of vascular or cardiac disease. Our aim was to evaluate the diagnosis, prevalence, imaging appearance, presumed embolic source, treatment, and outcome of patients with calcified cerebral emboli.
MATERIALS AND METHODS: Our radiology information system was searched for all CT scans by using keywords “calcified,” “emboli,” and their permutations. The radiology information system was also searched to identify all “stroke” CT reports to calculate the prevalence of calcified cerebral emboli. We also performed a MEDLINE search to identify all published case reports.
RESULTS: Twenty-two cases were identified from our database, and 48 were cases reported from the literature. The middle cerebral artery was the site of 83% of calcified emboli. Presumed sources were calcific aortic stenosis (36%), carotid atherosclerotic plaque (30%), and mitral annular calcification (11%). Spontaneous embolism occurred in 86%. Surgical treatment was performed in 34% of patients. Sixty-four percent of the patients with calcified aortic stenosis underwent aortic valve replacement. Among those with identifiable arterial disease, 53% underwent endarterectomy. Forty-one percent of patients experienced at least 1 recurrent stroke. The prevalence of calcified cerebral emboli identified on stroke CT scans at our institution was 2.7%. Seventy-three percent of cases were correctly identified. Twenty-seven percent were misdiagnosed on initial interpretation, while 9% were overlooked on preliminary interpretation.
CONCLUSIONS: Calcified cerebral emboli are more common than previously assumed, are frequently overlooked or misinterpreted, affect clinical course when diagnosed, and carry substantial risk for recurrent stroke.
Calcified cerebral emboli are a rarely reported but potentially devastating cause of stroke and may be the first manifestation of vascular or cardiac disease. Proper identification can guide treatment toward preventing future embolic events, neurologic impairment, and death. Noncontrast CT of the head is the most common imaging procedure used as the initial assessment of suspected stroke. The first imaging report of calcified cerebral emboli was published in 1981.1 Since then, there have been only 48 cases reported in the literature.1⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–38
The purpose of this study was to evaluate the diagnosis, prevalence, imaging appearance, presumed embolic source, treatment, and outcome of patients with calcified cerebral emboli. We report the first comprehensive review of the literature and present the largest imaging series to date, to our knowledge. We demonstrate that these emboli are more common than previously assumed, are frequently overlooked, and carry substantial risk for recurrent stroke.
Materials and Methods
In this institutional review board–approved study, our institutional radiology information system was searched for all noncontrast head CT scans obtained between 2001 and 2013 by using keywords “calcified,” “emboli,” and their permutations. Cases were identified and then reviewed by 2 board-certified neuroradiologists.
The radiology information system was also searched retrospectively for 12 consecutive months to identify all CT scan reports that contained the word “stroke” within the indication or body of the report. We reviewed all “stroke” NCCT scans and identified all cases with calcified cerebral emboli to calculate the prevalence among all patients obtaining a NCCT scan for stroke in the index period.
We also performed a MEDLINE search for “calcified” AND “emboli” AND “stroke” to identify all published case reports of calcified cerebral emboli diagnosed on imaging.
Results
Twenty-two cases were identified from our institutional database, and 48 cases were identified in the literature. Seventy cases were used in our statistical analysis.
Demographics
Of the 70 cases, 61% were men and 39% women. The mean patient age was 66 years (range, 20–91 years). Sixty-eight (97%) of the 70 patients presented with neurologic symptoms concerning for stroke, while 2 patients (3%) had incidental findings of calcified emboli without acute symptoms. All 70 had noncontrast head CT scans (Fig 1). Twenty-one patients were further evaluated with CT angiography (Fig 2), and 27 patients, by MR imaging (Fig 3).
During the 12-month index period, 452 stroke head CT scans were obtained in our institution. Twelve of the 22 cases of calcified cerebral emboli occurred during this time. The prevalence of calcified cerebral emboli identified on stroke CT scans at our institution during the index period was 2.7%.
Location
The middle cerebral artery was the most common site with 83% of all calcified emboli located as follows: M1 (26%), M2 (24%), M3 (11%), and M4 (22%). The anterior (8%) and posterior (8%) cerebral arteries were the next most common sites. One calcified embolus (1%) lodged within the supraclinoid internal carotid artery.
Multiple calcified emboli were observed in 37% of patients (Fig 1). Bilateral emboli were observed in 13% of patients and were equally distributed between hemispheres. The maximum number of calcified cerebral emboli was 6, with an average of 1.7. Repeat imaging, when available, demonstrated distal migration of calcified emboli in 14% of cases. Following intravenous thrombolytic administration, 4 patients had lysis of a calcified embolus with distal migration of multiple calcified fragments that were identified on repeat scan.
Size, Density, and Configuration
The average diameter of emboli was 2.5 mm with a range of 1.0–5.5 mm. Mean embolus attenuation was 162 HU, with a range from 79 to 435 HU. All emboli were either round (82%) or ovoid (18%).
Source
Potential embolic sources were identified by using echocardiography, sonography, and CT angiography. Presumed sources were calcified aortic stenosis (36%), carotid atherosclerotic plaque (30%), mitral annular calcification (11%), aortic arch atherosclerotic plaque (4%), brachiocephalic artery atherosclerotic plaque (3%), and vertebral atherosclerotic plaque (1%). An embolic source was not reported in 14% of patients.
Eighty-six percent of calcified emboli were spontaneous, while 14% were identified as nonspontaneous events: 9% following left heart catheterization, 3% following carotid artery manipulation, and 3% following cardiopulmonary resuscitation.
Treatment
Heparin therapy was administered in 24% of all patients. Thrombolytic therapy was administered to 9 patients (13%). Postembolic surgical treatment was performed in 24 (34%) patients. Sixty-four percent of surviving patients with calcified aortic stenosis underwent successful aortic valve replacement. Among those with identifiable arterial disease, 53% underwent successful endarterectomy.
Outcome
Data from the 22 cases at our institution showed that 43% of patients with initial CT evidence of calcified cerebral emboli subsequently experienced recurrent stroke, defined as >1 hospital presentation for stroke symptoms or imaging evidence of prior infarct on the initial study.
Nine patients received intravenous thrombolytic therapy with symptom improvement in 4 (44%) of 9. Residual neurologic impairment from calcified emboli occurred in 33% of cases. Complete neurologic recovery was seen in 29%. Sixteen percent of patients died during the initial hospitalization. In 23% of cases, there was no record or follow-up of neurologic outcome.
Diagnosis
Of the 22 cases at our institution, 73% were correctly identified as having calcified emboli on NCCT. Twenty-seven percent were misdiagnosed on initial NCCT interpretation as having hemorrhage, infectious, traumatic, or vascular calcification (Fig 3). These were only correctly diagnosed on the review for this study. Nine percent were overlooked on preliminary interpretation by the on-call radiology resident.
Discussion
Noncontrast CT is the most frequently used technique to screen patients with a clinical diagnosis of acute “stroke.” Initial NCCT scan findings—even those obtained in the first 6 hours following ictus—are abnormal in most patients with acute ischemic stroke. Positive imaging findings include a hyperattenuating vessel with intraluminal thrombus (eg, the “attenuated MCA” sign and “dot” sign), cortical and/or basal ganglia edema with blurring of gray-white matter interfaces (eg, the “insular ribbon” and “disappearing basal ganglia” signs), and early mass effect with sulcal effacement.39 To these widely recognized signs, we add a frequently overlooked but very important finding, calcified cerebral emboli.
Calcified emboli as a specific cause of stroke have been considered rare, with just 48 cases reported in the literature since the first description in 1981.1 In a single calendar year, we identified ≥1 calcified emboli in 2.7% of all patients undergoing NCCT with the clinical indication of stroke. We also found that patients with documented calcified emboli are at significant risk for recurrent embolic infarcts, with nearly half (43%) experiencing at least 1 repeat stroke.
While previous reports have suggested that calcified cerebral emboli most commonly occur following manual dislodgement (eg, left heart catheterization, valve surgery, carotid artery manipulation), our data suggest that most of such strokes (86%) are spontaneous and occur in the absence of such provoking events.4
A putative embolic source could be identified in 86% of all reported cases. Cardiac valvular disease was more common than carotid atheromatous disease, with calcific aortic stenosis 3 times as common as mitral valve disease as the embolic source. More than one-third (34%) of patients with calcified emboli subsequently underwent a surgical intervention. Valve replacement was performed in nearly two-thirds of those with calcific aortic stenosis, and endarterectomy was performed in 53% of those with arterial disease.
Calcified cerebral emboli are often small (2–3 mm in diameter) and can be easily overlooked or mistaken for other diseases. More than one-quarter of cases at our institution were initially missed entirely or misinterpreted on initial evaluation. Common misdiagnoses included hemorrhage, vessel wall calcification, or infectious residua. All calcified emboli were significantly more attenuated (162 HU) than intraluminal thrombi (typically 50–70 HU) and were round or ovoid (not tubular or linear like vascular wall calcification). In no cases were parenchymal calcifications suggestive of neurocysticercosis or other infections identified.
Cardioembolic stroke is considered the most severe ischemic stroke subtype, with a high risk of recurrence and high mortality.40 Patients with calcified cerebral emboli identified on NCCT should undergo further imaging to determine an embolic source because timely surgical intervention may prevent repeat ischemic episodes.
The retrospective nature of our radiology information system search may have led to bias because there is an increased sensitivity to identification of calcified emboli in our review of cases for this project. The residents and faculty at our institution have been educated on these findings and, therefore, have an increased awareness of identifying calcified emboli. This is evidenced by the fact that our index year accounts for more than half of all institutional cases in a 13-year period. Because we identified cases on the basis of search terms alone, it is assumed that a large number of cases were not identified that would otherwise have been included had we visually searched through the thousands of NCCT scans obtained for stroke during the 13-year study period. This limitation suggests that reported calcified emboli in our radiology information system are probably a gross underestimation of the real disease prevalence.
Conclusions
Calcified cerebral emboli are more common than previously assumed and occur in nearly 3% of patients obtaining a head CT scan for stroke. They are also frequently misinterpreted or overlooked. Calcified cerebral emboli carry a substantial risk for recurrent stroke with almost half of all patients experiencing a subsequent event. When properly diagnosed, patients with calcified cerebral emboli may be able to undergo surgical correction of underlying cardiac or vascular disease to prevent recurrence. These findings support the need for increased recognition of calcified cerebral emboli and further imaging to establish a presumed source of emboli.
Acknowledgments
The authors acknowledge and thank LuAnn Brigham for her valuable expertise in performing database queries.
Footnotes
Disclosures: Anne G. Osborn—UNRELATED: Board Membership: Amirsys, Amirsys Publishing, Employment: Amirsys Publishing (CEO), Payment for Lectures (including service on Speakers Bureaus): Mallinckrodt, Comments: Neuroradiology from the Master, Royalties: Amirsys, Comments: book royalties, Stock/Stock Options: Amirsys, Amirsys Publishing, Comments: shareholder.
Paper previously presented at: Annual Meeting of the American Society of Neuroradiology, May 18–23, 2013; San Diego, California.
REFERENCES
- Received November 7, 2013.
- Accepted after revision January 1, 2014.
- © 2014 by American Journal of Neuroradiology